Envelope perturbation and AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002084:Butylated Hydroxytoluene / Q000627:therapeutic use; D006678:HIV / Q000187:drug effects*; D006801:Humans; D008563:Membrane Lipids
D008563:Membrane Lipids; C050629:viral envelope lipids; D002084:Butylated Hydroxytoluene